To validate the role of circulating LOX-1+PMN-MDSCs as a negative prognostic factor of survival, we analyzed blood samples obtained from 40 (R/M) HNSCC patients prospectively collected from an independent cohort (see Table 1 for the characteristics of the patients). This evidence concerns the gene OLR1 and head and neck squamous cell carcinoma.